Frontier Biotechnologies Inc. (SHA:688221)
China · Delayed Price · Currency is CNY 16.58
-0.43 (-2.53%)
Sep 9, 2026, 4:00 PM EDT
Frontier Biotechnologies Market Cap
Frontier Biotechnologies has a market cap or net worth of 6.21 billion as of September 9, 2026. Its market cap has increased by 8.37% in one year.
Market Cap
6.21B
Enterprise Value
5.92B
Revenue
378.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.58
ChartMarket Cap Chart
Since October 28, 2020, Frontier Biotechnologies's market cap has decreased from 10.76B to 6.21B, a decrease of -42.28%. That is a compound annual growth rate of -8.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 6.21B | -8.14% |
| Dec 31, 2025 | 6.76B | 84.94% |
| Dec 31, 2024 | 3.66B | -1.61% |
| Dec 29, 2023 | 3.72B | -42.53% |
| Dec 30, 2022 | 6.47B | -3.33% |
| Dec 31, 2021 | 6.69B | -3.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ZhuZhou QianJin Pharmaceutical Co.,Ltd | 6.82B |
| Hunan Er-Kang Pharmaceutical | 6.70B |
| Changchun BCHT Biotechnology Co. | 6.68B |
| Cisen Pharmaceutical | 6.57B |
| Hunan Warrant Pharmaceutical Co.,Ltd | 6.57B |
| KPC Pharmaceuticals,Inc. | 6.41B |
| Hainan Haiyao | 6.38B |
| Guizhou Bailing Group Pharmaceutical | 6.33B |